Skip to main content

Advertisement

SpringerLink
Log in

Nasolacrimal transition time in patients with multiple sclerosis

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

To measure the duration of nasolacrimal transition in patients with Multiple Sclerosis (MS), to compare the findings with the healthy population and to investigate the relationship between MS-related disability and nasolacrimal transition time.

Methods

A total of 73 individuals including 37 patients with relapsing–remitting MS and 36 healthy volunteers were included in the study. In both groups the nasolacrimal transition time was measured using flurosein drops. The degree of disability of MS patients was calculated according to the Expanded Disability Status Scale (EDSS).

Results

There was a significant difference between MS patients and control group in terms of the median value of nasolacrimal transition time in (240 s (min: 85, max: 724) and 58.5 s (min: 21, max: 428), respectively) (p < 0.001). A positive correlation was found between EDSS scores and nasolacrimal transition time of MS patients (r = 0.384, p = 0.019).

Conclusion

This study showed that nasolacrimal transition time is prolonged in MS patients and there is a relationship between the degree of MS-related disability and the nasolacrimal transition time. This is the first study in the literature on this subject and the results of our study have the potential to shed light on the causes of common infections in MS patients. Long-term prospective studies are needed to further investigate the relationship between prolonged nasolacrimal transition and infections in MS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kular L, Jagodic M (2020) Epigenetic insights into multiple sclerosis disease progression. J Intern Med 288:82–102

    Article  CAS  Google Scholar 

  2. Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O (2018) Multiple sclerosis. Lancet 391(10130):1622–1636

    Article  Google Scholar 

  3. Persson R, Lee S, Yood MU, Wagner CM, Minton N, Niemcryk S, Lindholm A, Evans AM, Jick SS (2020) Infections in patients diagnosed with multiple sclerosis: a multi-database study. MultSclerRelatDisord 41:101982

    CAS  Google Scholar 

  4. Steelman AJ (2015) Infection as an environmental trigger of multiple sclerosis disease exacerbation. Front Immunol 19(6):520

    Google Scholar 

  5. Marrodan M, Alessandro L, Farez MF, Correale J (2019) The role of infections in multiple sclerosis. MultScler 25(7):891–901

    Google Scholar 

  6. Wijnands JM, Kingwell E, Zhu F, Zhao Y, Fisk JD, Evans C, Marrie RA, Tremlett H (2017) Infection related health care utilization among people with and without multiple sclerosis. MultScler 23(11):1506–1516

    Google Scholar 

  7. Heath G, Airody A, Gale RP (2017) The ocular manifestations of drugs used to treat multiple sclerosis. Drugs 77:303–311

    Article  Google Scholar 

  8. Zecca C, Nessi F, Bernasconi E, Gobbi C (2009) Ocular toxoplasmosis during natalizumab treatment. Neurology 73(17):1418–1419

    Article  Google Scholar 

  9. Perry HD (2008) Dry eye disease: pathophysiology, classification, and diagnosis. Am J Manag Care 14(3 Suppl):S79-87

    PubMed  Google Scholar 

  10. Ali MJ, Paulsen F (2020) Human lacrimal drainage system reconstruction, recanalization, and regeneration. Curr Eye Res 45(3):241–252

    Article  Google Scholar 

  11. Prokosch V, Prokosch JE, Julia P, Idelevich EA, Böhm MRR, Thanos S, Stupp T (2014) Bacterial spectrum and antimicrobial susceptibility patterns in acquired and connatal lacrimal duct stenosis. Curr Eye Res 39(11):1069–1075

    Article  CAS  Google Scholar 

  12. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonaldcriteria. Lancet Neurol 17(2):162–173

    Article  Google Scholar 

  13. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1446

    Article  CAS  Google Scholar 

  14. Jones LT (1961) An anatomical approach to problems of the eyelids and lacrimal apparatus. Arch Ophthalmol 66(1):111–124

    Article  CAS  Google Scholar 

  15. Jones LT, Wobig JL (1991) Surgery of the eyelids and lacrimal system. Birmingham, Alabama: Aesculapius, 1976. Munden PM, Kardon RH, Denison CE, Carter KD. Palpebral fissure responses to topical adrenergic drugs. Am J Ophtalmol 111:706–710

    Article  Google Scholar 

  16. Becker BB (1990) Flexible endoscopy in primary dye testing of the lacrimal system. Ophthalmic Surg Lasers Imaging Retina 21(8):577–580

    Article  CAS  Google Scholar 

  17. Onerci M (2002) Dacryocystorhinostomy. Diagnosis and treatment of nasolacrimal canal obstructions. Rhinology 40(2):49–65

    CAS  PubMed  Google Scholar 

  18. Örnek N, Dağ E, Örnek K (2015) Corneal sensitivity and tear function in neurodegenerative diseases. Curr Eye Res 40(4):423–428

    Article  Google Scholar 

  19. Miro J, Peña-Sagredo JL, Berciano J, Insua S, Leno C, Velarde R (1990) Prevalence of primary Sjögren’s syndrome in patients with multiple sclerosis. Ann Neurol 27(5):582–584

    Article  CAS  Google Scholar 

  20. Annunziata P, De Santi L, Di Rezze S, Millefiorini E, Capello E, Mancardi G, RizM De, Scarpini E, Vecchio R, Patti F (2011) Clinical features of Sjogren’s syndrome in patients with multiple sclerosis. Acta NeurolScand 124(2):109–114

    Article  CAS  Google Scholar 

  21. Jones LT (1973) Anatomy of the tear system. Int OphthalmolClin 13(1):3–22

    Article  CAS  Google Scholar 

  22. Palakuru JR, Wang J, Aquavella JV (2007) Effect of blinking on tear dynamics. Invest Ophthalmol Vis Sci 48(7):3032–3037

    Article  Google Scholar 

  23. Zadro I, Barun B, Habek M, Brinar VV (2008) Isolated cranial nerve palsies in multiple sclerosis. ClinNeurolNeurosurg 110(9):886–888

    Google Scholar 

  24. Degirmenci E, Erdogan C, Bir LS (2013) Correlation between blink reflex abnormalities and magnetic resonance imaging findings in patients with multiple sclerosis. Acta Neurol Belg 113(3):265–269

    Article  Google Scholar 

  25. Klissurski M, Novachkova S, Pl T, Alexiev F (2009) Orbicularis oculi reflex abnormalities in patients with multiple sclerosis: a clinical, EMG, and MRI investigation. ElectromyogrClinNeurophysiol 49(1):59–63

    CAS  Google Scholar 

  26. Brooks JBB, Jardim MR, Papais-Alvarenga RM, Fragoso YD (2015) There is still a role for the blink reflex in the diagnosis and follow-up of multiple sclerosis. ClinNeurophysiol 126(4):743–747

    Google Scholar 

  27. DeAngelis D, Hurwitz J, Mazzulli T (2001) The role of bacteriologic infection in the etiology of nasolacrimal duct obstruction. Can J Ophthalmol 36(3):134–139

    Article  CAS  Google Scholar 

  28. Hartikainen J, Lehtonen O-P, Saari KM (1997) Bacteriology of lacrimal duct obstruction in adults. Br J Ophthalmol 81(1):37–40

    Article  CAS  Google Scholar 

  29. Li G, Guo J, Liu R, Hu W, Xu L, Wang J, Cai S, Zhang H, Zhu Y (2016) Lacrimal duct occlusion is associated with infectious keratitis. Int J Med Sci 13(10):800–805

    Article  Google Scholar 

  30. Sood AB, Kumar G, Robinson J (2016) Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab. J Ophthalmic Inflamm Infect 6(1):1–4

    Article  Google Scholar 

  31. Naiboglu B, Devecı I, Kalaycık C, Daylan A, Habesoglu TE, Toros SZ, Devecı SE, Egelı E (2010) Effect of nasolacrimal duct obstruction on nasal mucociliary transport. J LaryngolOtol 124(2):166–170

    Article  CAS  Google Scholar 

  32. Sahin E, Hamamcı M, KantekinY, (2020) Measurement of mucociliary clearance in the patients with multiple sclerosis. Eur Arch Otorhinolaryngol 277(2):469–473

    Article  Google Scholar 

  33. Gudis DA, Cohen NA (2010) Cilia dysfunction. OtolaryngolClin North Am 43(3):461–472

    Article  Google Scholar 

  34. Vinogradova Y, Hippisley-Cox J, Coupland C (2009) Identification of new risk factors for pneumonia: population-based case-control study. Br J Gen Pract 59(567):e329–e338

    Article  Google Scholar 

  35. Correale J, Fiol M, Gilmore W (2006) The risk of relapses in multiple sclerosis during systemic infections. Neurology 67(4):652–659

    Article  CAS  Google Scholar 

  36. Kale N, Magana S, Agaoglu J, Tanik O (2009) Assessment of autonomic nervous system dysfunction in multiple sclerosis and association with clinical disability. Neurol Int 1(5):15–18

    Google Scholar 

  37. Gunal DI, Afsar N, Tanridag T, Aktan S (2002) Autonomic dysfunction in multiple sclerosis: correlation with disease-related parameters. EurNeurol 48(1):1–5

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Yozgat Bozok University School of Medicine, Atatürk Yolu 7. Km, 66100, Yozgat, Turkey

    Hakan Dağıstan

  2. Department of Neurology, Yozgat Bozok University School of Medicine, Yozgat, Turkey

    Mehmet Hamamcı

Authors
  1. Hakan Dağıstan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehmet Hamamcı
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hakan Dağıstan.

Ethics declarations

Conflict of İnterest

The authors declare that they have no conflict of interest.

Human and animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Yozgat Bozok University Clinical Researches Ethic Committee Ref No: 2017-KAEK-189ˍ2019.12.25ˍ14) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dağıstan, H., Hamamcı, M. Nasolacrimal transition time in patients with multiple sclerosis. Eur Arch Otorhinolaryngol 278, 3357–3362 (2021). https://doi.org/10.1007/s00405-021-06603-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-021-06603-0

Keywords

Search

Navigation